139 related articles for article (PubMed ID: 23682236)
1. Successful treatment of recurrent follicular B-cell lymphoma with clarithromycin, prednisolone, and cyclophosphamide.
Ohe M; Hashino S
Korean J Intern Med; 2013 May; 28(3):377-9. PubMed ID: 23682236
[No Abstract] [Full Text] [Related]
2. Clinical and molecular complete remission of primary duodenal follicular lymphoma following treatment with rituximab and cyclophosphamide, vincristine and prednisone chemotherapy.
Falorio S; Angrilli F; Fioritoni G
Intern Med J; 2009 Oct; 39(10):706-7. PubMed ID: 19849763
[No Abstract] [Full Text] [Related]
3. B-cell follicular lymphoma presenting as facial papules.
Valejo Coelho MM; Borges AS; Fernandes C; Ribeiro P; João A; Carvalho R
J Dtsch Dermatol Ges; 2018 Dec; 16(12):1493-1495. PubMed ID: 30417543
[No Abstract] [Full Text] [Related]
4. Rituximab-induced serum sickness in a patient with follicular lymphoma.
Disperati P; Hicks LK; Buckstein R
Leuk Lymphoma; 2007 Aug; 48(8):1633-5. PubMed ID: 17701597
[No Abstract] [Full Text] [Related]
5. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
[TBL] [Abstract][Full Text] [Related]
6. [Economic analysis of rituximab in combination with cyclophosphamide, vincristine and prednisolone in the treatment of patients with advanced follicular lymphoma in Portugal].
Braga P; Carvalho S; Gomes M; Guerra L; Lúcio P; Marques H; Negreiro F; Pereira C; Silva C; Teixeira A
Acta Med Port; 2010; 23(6):1025-34. PubMed ID: 21627880
[TBL] [Abstract][Full Text] [Related]
7. 'The sandwich sign' of mesenteric lymphoma.
Hokama A; Nakamoto M; Kinjo F; Fujita J
Eur J Haematol; 2006 Oct; 77(4):363-4. PubMed ID: 16856921
[No Abstract] [Full Text] [Related]
8. Carotid sinus syncope in a patient with relapsed cervical lymphoma.
Takahashi T; Obata N; Sugawara N; Fujita K; Oikawa K; Yoshimoto M; Urabe K; Nishimura M; Tsujisaki M
Int J Hematol; 2006 Jul; 84(1):92-3. PubMed ID: 16867911
[No Abstract] [Full Text] [Related]
9. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group.
Hiddemann W; Kneba M; Dreyling M; Schmitz N; Lengfelder E; Schmits R; Reiser M; Metzner B; Harder H; Hegewisch-Becker S; Fischer T; Kropff M; Reis HE; Freund M; Wörmann B; Fuchs R; Planker M; Schimke J; Eimermacher H; Trümper L; Aldaoud A; Parwaresch R; Unterhalt M
Blood; 2005 Dec; 106(12):3725-32. PubMed ID: 16123223
[TBL] [Abstract][Full Text] [Related]
10. Management of relapsed/refractory follicular lymphoma.
Martin P
Clin Adv Hematol Oncol; 2018 Apr; 16 Suppl 10(4):1-12. PubMed ID: 29851937
[No Abstract] [Full Text] [Related]
11. Case report: severe CMV colitis in a patient with follicular lymphoma after chemotherapy.
Polprasert C; Wongjitrat C; Wisedopas N
J Med Assoc Thai; 2011 Apr; 94(4):498-500. PubMed ID: 21591537
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic pemphigus in two patients with B-cell non-Hodgkin's lymphoma: significant responses to cyclophosphamide and prednisolone.
Hertzberg MS; Schifter M; Sullivan J; Stapleton K
Am J Hematol; 2000 Feb; 63(2):105-6. PubMed ID: 10629583
[No Abstract] [Full Text] [Related]
13. Rethinking Prognosis and Therapy for Follicular Lymphoma.
Jacobson CA; Freedman AS
J Clin Oncol; 2015 Aug; 33(23):2489-91. PubMed ID: 26169620
[No Abstract] [Full Text] [Related]
14. Hematology: Follicular lymphoma: maintenance therapy is (often) indicated.
Seymour JF
Nat Rev Clin Oncol; 2009 Nov; 6(11):624-6. PubMed ID: 19861993
[No Abstract] [Full Text] [Related]
15. Hematology: The case against rituximab maintenance.
Cheson BD
Nat Rev Clin Oncol; 2009 Nov; 6(11):622-4. PubMed ID: 19861992
[No Abstract] [Full Text] [Related]
16. Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas.
Rohatgi N; LaRocca RV; Bard V; Sethuraman G; Foon KA
Am J Hematol; 2002 Jul; 70(3):181-5. PubMed ID: 12111762
[TBL] [Abstract][Full Text] [Related]
17. Adding rituximab to cyclophosphamide, vincristine and prednisone increases time to treatment failure or progression in people with untreated stage III/IV follicular lymphoma.
Ghielmini M
Cancer Treat Rev; 2005 Dec; 31(8):644-7. PubMed ID: 16289339
[No Abstract] [Full Text] [Related]
18. Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases.
Kornacker M; Kraemer A; Leo E; Ho AD
Ann Hematol; 2002 Feb; 81(2):103-5. PubMed ID: 11907791
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for bortezomib combinations in the management of patients with follicular lymphoma?
Salles G
J Clin Oncol; 2011 Sep; 29(25):3349-50. PubMed ID: 21810690
[No Abstract] [Full Text] [Related]
20. Efficacy of fludarabine/mitoxantrone/dexamethasone alternating with CHOP in bulky follicular non-Hodgkin's lymphoma.
Wilder DD; Ogden JL; Jain VK
Clin Lymphoma; 2002 Mar; 2(4):229-37. PubMed ID: 11970762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
